Paul A. Jones - 23 Oct 2021 Form 4 Insider Report for USANA HEALTH SCIENCES INC (USNA)

Role
Chief Leadership Dev Officer
Signature
Joshua Foukas, as attorney in fact.
Issuer symbol
USNA
Transactions as of
23 Oct 2021
Net transactions value
$0
Form type
4
Filing time
26 Oct 2021, 21:11:58 UTC
Next filing
05 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction USNA Common Stock Options Exercise +549 +7.7% 7,714 23 Oct 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction USNA Restricted Stock Units Options Exercise $0 -549 -4.4% $0.000000 11,923 23 Oct 2021 Common Stock 549 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of USNA common stock.
F2 On October 23rd, 2017, the reporting person was granted 2,198 restricted stock units, vesting at 25% on each 23rd of October thereafter.